News & Perspective

Apr 01, 2004

Apr 01, 2004

IDSA urges Bayer to stop selling enrofloxacin

(CIDRAP News) – The Infectious Diseases Society of America (IDSA) is urging Bayer Corp. to comply with a proposed federal regulatory action and withdraw enrofloxacin (Baytril) from the market because of the concern that its use in poultry promotes drug-resistant bacteria.

Mar 17, 2004

Mar 17, 2004

Benign rashes seen in first-time smallpox vaccinees

(CIDRAP News) – Nine out of 250 people who received their first smallpox shots in a recent study reacted with a variety of self-limiting skin rashes, a side effect that could be mistaken for a serious reaction to the vaccine, according to a report in Clinical Infectious Diseases.

Feb 24, 2004

Feb 24, 2004

Y pseudotuberculosis infections traced to lettuce

(CIDRAP News) – An unusual intestinal infection that is often mistaken for appendicitis has been traced to a specific food source, iceberg lettuce, for the first time, according to a report in the Mar 1 Journal of Infectious Diseases (JID).

Aug 29, 2003

Aug 29, 2003

Early detection and hospital preparedness called major SARS concerns

(CIDRAP News) – Worries about the ability to quickly detect a return of SARS (severe acute respiratory syndrome) and about hospitals' ability to handle a large number of patients were two leading issues at a recent national meeting on SARS preparedness, according to a participating physician.

Dec 11, 2002

Dec 11, 2002

Infectious disease experts oppose smallpox shots for public

(CIDRAP News) – The 7,000-member Infectious Diseases Society of America (IDSA) has urged President Bush not to make smallpox vaccine available to the public for now, on grounds that serious reactions to it could undermine public confidence in the shots and in other immunizations as well.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»